Systematic review demonstrates prebiotic and metabolic benefits of fungal polysaccharides, suggesting therapeutic potential for colitis and diabetes.
Medicinal and edible fungal polysaccharides (MEFPs) are fungal bioactive carbohydrates. This review systematically summarizes their sources, preparation, structural characteristics and health benefits as prebiotics. Most MEFPs derive from Basidiomycota with specific molecular structures and monosaccharide compositions. Optimized extraction and purification methods ensure their structural integrity. MEFPs regulate gut microbiota, improve lipid metabolism and immunity, and exhibit therapeutic potential for colitis, diabetes and obesity.
No takes yet. Share an insight, caveat, or question.
Ruli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: